PharMEDium Services, LLC. is recalling 499 syringes of Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection (1 mL) because testing revealed the medication is superpotent, meaning it contains more active drug than specified. This prescription pain medication is packaged in syringes and was distributed to healthcare facilities in California and Illinois. Consumers should immediately contact their healthcare provider or pharmacist regarding this recall, as the use of higher-than-intended doses of this medication poses serious health risks.
The drug is superpotent and failed potency specifications, which means patients could receive a much higher dose of hydromorphone than prescribed. An overdose of this potent opioid can lead to severe respiratory depression, extreme sedation, and potentially life-threatening complications.
Contact healthcare provider and return product for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.